Your browser doesn't support javascript.
Ki-67 expression level in placentas with COVID-19 infected women
Journal of Drug Delivery and Therapeutics ; 12(1-s):29-33, 2022.
Article in English | CAB Abstracts | ID: covidwho-1876380
ABSTRACT

Objective:

The SARS-CoV-2 virus, which emerged in December 2019 in Wuhan, China, spread very quickly in a short time and was declared a pandemic by the World Health Organization in March 2020. Physiological and immunological changes during pregnancy cause complications in respiratory tract infections. Complications by COVID-19 lead to a systemic effect that causes maternal and fetal mortality and morbidity. In this study, we aimed to investigate histopathological changes and Ki-67 expression in placentas of women with positive COVID-19 infection. Study

Design:

Placentas of 10 samples COVID-19 positive and 10 samples Covid-19 negative pregnant patients who were hospitalized in the Gynecology and Obstetrics Clinic of Dicle University Faculty of Medicine were included in the study. Placental tissues were fixed in 10% formaldehyde (24 hours) and processed for routine paraffin wax tissue staining. Hematoxylin Eosin dye and Ki-67 immunohistochemical staining were performed.
Keywords

Full text: Available Collection: Databases of international organizations Database: CAB Abstracts Language: English Journal: Journal of Drug Delivery and Therapeutics Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: CAB Abstracts Language: English Journal: Journal of Drug Delivery and Therapeutics Year: 2022 Document Type: Article